Point72 »

Bicara Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Bicara Therapeutics shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 56k 25.47

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Deerfield Management Company
Braidwell
T. Rowe Price Associates
Fairmount Funds Management
Baker Bros. Advisors
Blackstone Group
First Turn Management
Vestal Point Capital
Point72 Asset Management
Woodline Partners
OrbiMed Advisors
Citadel Advisors

View all funds holding Bicara Therapeutics